Pharmacy organisations have welcomed the new PSA CEO, signalling the important role he will have in continuing to progress partnerships with the industry
The Pharmacy Guild of Australia and the Society of Hospital Pharmacists of Australia have welcomed the appointment of Mark Kinsela to the CEO position at the PSA.
Mr Kinsela will formally begin his new role on 2 December 2019.
The Guild congratulated Mr Kinsela, with Guild executive director Suzanne Greenwood saying he will bring invaluable experience to the role.
“Mr Kinsela brings broad knowledge of the health sector as well as executive experience to this important position of leadership,” Ms Greenwood says.
”I look forward to working with Mr Kinsela at what is a very important time for community pharmacy and for the patients we serve.
“The sector faces increasing challenges, but I am confident that working together for the good of the profession and our patients we can achieve strong and positive outcomes.
“I would also like to thank interim CEO Shane Jackson with whom the Guild has worked closely over the past months.”
The SHPA also recognised the importance of the new appointment.
“For decades SHPA and PSA have worked side-by-side to support and represent Australia’s pharmacists and pharmacy technicians, and it was a pleasure to attend the signing of a Memorandum of Understanding between our organisations at PSA19 in July this year,” said SHPA chief executive Kristin Michaels.
“With medication safety recently declared Australia’s next National Health Priority Area by Health Minister Greg Hunt, I look forward to very close and positive collaboration as we work together to best represent our members and deliver on our shared vision to improve the quality and safe use of medicines for all Australians.”
Ms Michaels says the tenure of Dr Jackson and the concurrent release of strategic plans from the two organisations has heralded a time of unparalleled cooperation and opportunity.
“I thank Dr Jackson both personally and on behalf of our members for his leadership this year, which has seen closer alignment between SHPA and PSA for the benefit of patients, consumers, the pharmacy profession and the broader community.
“With both SHPA and PSA releasing five-year strategic plans this year, I look forward to working with Mr Kinsela to progress our mutual goals, as we empower and equip SHPA and PSA members to improve the safe and quality use of medicines for all Australians.”
Consumer Healthcare Products (CHP) Australia also congratulated Mr Kinsela.
“CHP Australia has always enjoyed a collaborative relationship with the PSA, working together to improve health outcomes through responsible self care,” says CHP Australia CEO, Dr Deon Schoombie.
“We look forward to continuing that relationship under the leadership of Mr Kinsela.
“We are particularly eager to work with Mr Kinsela, a health policy expert, to increase access to non-prescription medicines through rescheduling, and to empower consumers by improving health literacy.”
CHP Australia also acknowledged the contributions of outgoing acting CEO Dr Jackson, and thank him for his collaborative approach.